Loading...
XKRX
007570
Market cap158mUSD
Sep 10, Last price  
13,050.00KRW
Name

Ilyang Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XKRX:007570 chart
P/E
22.84
P/S
0.87
EPS
571.46
Div Yield, %
Shrs. gr., 5y
0.23%
Rev. gr., 5y
-3.70%
Revenues
268.86b
+3.79%
129,862,634,000120,289,302,000114,614,743,000147,689,522,000138,485,382,000141,162,847,320146,460,716,530147,731,713,180211,797,503,490186,285,485,380261,614,907,970269,811,002,650300,036,331,830324,573,436,600343,328,723,950371,347,508,040383,810,821,780259,042,263,250268,861,230,000
Net income
10.26b
-10.96%
3,110,883,0001,003,252,000-16,079,811,0001,065,748,0001,975,802,0001,386,265,0502,073,286,5903,963,178,000-10,961,991,0003,617,616,0005,905,742,0006,264,568,000-4,893,034,00019,594,666,72021,545,309,78025,955,713,96031,741,017,76011,519,585,56010,257,274,000
CFO
5.61b
-71.03%
5,645,343,000-2,875,366,000-1,631,673,000-9,441,306,00015,474,104,000-26,621,705,9304,426,532,760-3,036,392,13018,628,602,71021,788,068,54027,040,532,73030,025,336,00022,120,200,80036,192,694,56057,484,189,26067,020,184,27029,936,129,02019,382,377,8815,614,846,000
Dividend
Dec 27, 2023150 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and beverages. In addition, the company offers pharmaceutical raw materials products, such as aluminum hydroxide gel, dried aluminum hydroxide gel, magnesium hydroxide, magnesium hydroxide gel, aluminum hydroxide-magnesium carbonate co-dried gel, magnesium trisilicate, hydrotalcite, almagate, aluminum phosphate, aluminum phosphate gel, aluminum magnesium metasilicate, aluminum magnesium silicate, aluminum magnesium silicopolydrate, magaldrate, magaldrate wet gel, dihydroxy aluminum sodium carbonate, magnesium carbonate, aluminum magnesium hydroxide, synthetic aluminum silicate, and other products. Ilyang Pharmaceutical Co.,Ltd also exports its products to approximately 14 countries. The company was formerly known as Il-Yang Pharm. Ind. Co. and changed its name to Ilyang Pharmaceutical Co., Ltd. in May 1991. Ilyang Pharmaceutical Co.,Ltd was founded in 1946 and is headquartered in Yongin, South Korea.
IPO date
Aug 28, 1974
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT